DLA Piper

With considerable depth of experiences and resources throughout Hong Kong, Beijing and Shanghai, the China private equity practice at DLA Piper assists clients throughout the entire PE life cycle, with particular sector specialisms spanning technology, automobiles, life sciences, pharmaceuticals and chemicals. Shanghai-based Qiang Li specialises in high-end cross-border transactions, whilst Stewart Wang focuses on venture capital investment, FDI and joint ventures; the pair combining to advise Wise Road Capital on the regulatory aspects of its $9.4bn acquisition of Chinese chip-making giant Tsinghua Unigroup. In Beijing, James Chang brings deep transactional and regulatory expertise and regularly advises investors and companies on early stage and growth capital investments. Corporate and PE specialist Xin Fang joined the team from Mayer Brown in January 2023 and is based in Hong Kong.